Biologics to the rescue - New Straits Times
March 26, 2007| Biologics to the rescue New Straits Times, Malaysia - Biologics is a breakthrough treatment for rheumatoid arthritis but it is costly, writes MANVEET KAUR. FIVE years ago, Professor Narehan Hassan woke up one ... |
Biotech Implosion: CombinatoRx (CRXX) - 24/7 Wall St.
March 26, 2007| Biotech Implosion: CombinatoRx (CRXX) 24/7 Wall St., NY - Comparison of treatment outcomes for CRx-102 (from previously reported results in RA) versus very low dose prednisolone alone (from the study reported here) ... |
European Union CHMP Recommends Approval of First and Only Biologic ... - PharmaLive.com (press release)
March 26, 2007| European Union CHMP Recommends Approval of First and Only Biologic ... PharmaLive.com (press release), PA - REMICADE treatment is to be initiated and supervised by qualified physicians experienced in the diagnosis and treatment of rheumatoid arthritis, ... |
Trubion Pharmaceuticals, Inc. Reports Fourth Quarter and Year ... - MSN Money
March 26, 2007| Trubion Pharmaceuticals, Inc. Reports Fourth Quarter and Year ... MSN Money - ... for its lead product candidate, TRU-015, which is currently being tested in a Phase IIb clinical trial for the treatment of rheumatoid arthritis. ... |
European Union CHMP Recommends Approval of First and Only Biologic ... - PR Newswire UK (press release)
March 26, 2007| European Union CHMP Recommends Approval of First and Only Biologic ... PR Newswire UK (press release), UK - REMICADE treatment is to be initiated and supervised by qualified physicians experienced in the diagnosis and treatment of rheumatoid arthritis, ... |
EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds - PR Newswire (press release)
March 26, 2007| EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds PR Newswire (press release), NY - ... cell cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. ... |
Amgen Discontinues Vectibix(TM) Treatment In PACCE Trial ... - Medical News Today (press release)
March 26, 2007| Amgen Discontinues Vectibix(TM) Treatment In PACCE Trial ... Medical News Today (press release), UK - ... helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. ... Amgen Discontinues Vectibix(TM) Treatment In PACCE Trial ... |
European Union CHMP Recommends Approval of First and Only Biologic ... - PR Newswire (press release)
March 26, 2007| European Union CHMP Recommends Approval of First and Only Biologic ... PR Newswire (press release), NY - REMICADE treatment is to be initiated and supervised by qualified physicians experienced in the diagnosis and treatment of rheumatoid arthritis, ... |
UCB Provides Update on CIMZIA(TM) for Crohn's Disease and ... - Genetic Engineering News (press release)
March 26, 2007| UCB Provides Update on CIMZIA(TM) for Crohn's Disease and ... Genetic Engineering News (press release), NY - UCB plans to file a Biologics License Application (BLA) with the FDA for CIMZIATM in the treatment of rheumatoid arthritis by year end 2007. ... |